Published in Osteoporos Int on July 10, 2012
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int (2006) 11.05
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2008) 5.27
The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res (1996) 3.25
The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol (2009) 3.03
The crippling consequences of fractures and their impact on quality of life. Am J Med (1997) 2.98
Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas (2009) 2.74
Survival after hip fracture: short- and long-term excess mortality according to age and gender. Osteoporos Int (1999) 2.28
Epidemiology of hip fractures in Oslo, Norway. Bone (2001) 2.01
Functional outcome and quality of life following hip fracture in elderly women: a prospective controlled study. Osteoporos Int (2003) 1.91
Trends in drug prescribing for osteoporosis after hip fracture, 1995-2004. J Rheumatol (2007) 1.80
Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8 years of service provision. Osteoporos Int (2011) 1.55
Prevalence and predictors of osteoporosis treatment in nursing home residents with known osteoporosis or recent fracture. Osteoporos Int (2006) 1.49
Consequences of hip fracture on activities of daily life and residential needs. Osteoporos Int (2004) 1.44
The burden of hospitalised fractures in Sweden. Osteoporos Int (2004) 1.41
Access to osteoporosis treatment is critically linked to access to dual-energy x-ray absorptiometry testing. Med Care (2007) 1.36
Medication use patterns for osteoporosis: an assessment of guidelines, treatment rates, and quality improvement interventions. Mayo Clin Proc (2005) 1.32
Prevalence of osteoporosis by educational level in a cohort of postmenopausal women. Osteoporos Int (1999) 1.25
Osteoporosis prevalence and levels of treatment in primary care: the Australian BoneCare Study. J Bone Miner Res (2004) 1.20
Oral bisphosphonates are associated with reduced mortality after hip fracture. Osteoporos Int (2010) 1.17
Undertreatment with anti-osteoporotic drugs after hospitalization for fracture. Osteoporos Int (2003) 1.17
Predictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USA. Osteoporos Int (2009) 1.12
Population-based geographic variations in DXA bone density in Europe: the EVOS Study. European Vertebral Osteoporosis. Osteoporos Int (1997) 1.06
Undertreatment of osteoporosis following hip fracture in the elderly. Arch Gerontol Geriatr (2008) 0.93
Treatment of osteoporosis among older adults discharged from hospital in Italy. Eur J Clin Pharmacol (2001) 0.89
Initiation of anti-osteoporotic therapy in patients with recent fractures: a nationwide analysis of prescription rates and persistence. Osteoporos Int (2008) 0.88
Osteoporosis pharmacotherapy following bone densitometry: importance of patient beliefs and understanding of DXA results. Osteoporos Int (2010) 0.86
Factors predicting osteoporosis treatment initiation in a regionally based cohort. Osteoporos Int (2008) 0.85
Barriers to effective management of osteoporosis in moderate and minimal trauma fractures: a prospective study. Osteoporos Int (2004) 0.82
[Osteoporosis and fractures in Norway. Occurrence and risk factors]. Tidsskr Nor Laegeforen (1998) 0.81
Prescription of anti-osteoporosis drugs during 2004-2007-a nationwide register study in Norway. Eur J Clin Pharmacol (2009) 0.80
The burden of previous fractures in hip fracture patients. The Break Study. Aging Clin Exp Res (2011) 0.78
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J (2003) 17.80
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Health consequences of smoking 1-4 cigarettes per day. Tob Control (2005) 3.47
Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register. Arthritis Rheum (2000) 2.71
Cloning and expression of human arylsulfatase A. J Biol Chem (1989) 2.55
Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study. Am J Clin Nutr (2000) 2.53
Primary structure of the beta subunit of the DHP-sensitive calcium channel from skeletal muscle. Science (1989) 2.40
Factors associated with mortality after hip fracture. Osteoporos Int (2000) 2.35
Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA (1995) 2.31
Survival after hip fracture: short- and long-term excess mortality according to age and gender. Osteoporos Int (1999) 2.28
Is blood pressure treatment as effective in a population setting as in controlled trials? Results from a prospective study. J Hypertens (1994) 2.19
Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trøndelag Health Survey. Diabetologia (1999) 2.07
Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. Gut (1997) 2.04
Epidemiology of hip fractures in Oslo, Norway. Bone (2001) 2.01
Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study. Am J Clin Nutr (2001) 1.84
Risk factors for hip fracture in middle-aged Norwegian women and men. Am J Epidemiol (1993) 1.78
UGA is translated as cysteine in pheromone 3 of Euplotes octocarinatus. Proc Natl Acad Sci U S A (1991) 1.77
Reduced bone mineral density in male rheumatoid arthritis patients: frequencies and associations with demographic and disease variables in ninety-four patients in the Oslo County Rheumatoid Arthritis Register. Arthritis Rheum (2000) 1.77
Mortality associated with vertebral deformity in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (1998) 1.76
Cohort study of coffee intake and death from coronary heart disease over 12 years. BMJ (1996) 1.70
Phylogenetic conservation of arylsulfatases. cDNA cloning and expression of human arylsulfatase B. J Biol Chem (1990) 1.69
Cost and health consequences of reducing the population intake of salt. J Epidemiol Community Health (2000) 1.62
The rubber elongation factor of rubber trees (Hevea brasiliensis) is the major allergen in latex. J Allergy Clin Immunol (1993) 1.60
Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. The Nord-Trøndelag Health Surveys: 1984-1986 and 1995-1997. Diabetes Care (1999) 1.59
Sequence analysis of phosphoserine-containing peptides. Modification for picomolar sensitivity. FEBS Lett (1986) 1.58
Metabolism of Indole-3-Acetic Acid: II. Oxindole Pathway in Parthenocissus tricuspidata Crown-Gall Tissue Cultures. Plant Physiol (1976) 1.58
Does hip strength analysis explain the lower incidence of hip fracture in the People's Republic of China? Bone (2004) 1.57
An investigation of the substrate specificity of protein phosphatase 2C using synthetic peptide substrates; comparison with protein phosphatase 2A. Biochim Biophys Acta (1990) 1.56
Incidence of limb fracture across Europe: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (2002) 1.56
Amino acid sequences of a-factor mating peptides from Saccharomyces cerevisiae. J Biol Chem (1987) 1.56
Endothelial nitric-oxide synthase (type III) is activated and becomes calcium independent upon phosphorylation by cyclic nucleotide-dependent protein kinases. J Biol Chem (2000) 1.55
The Nordic prescription databases as a resource for pharmacoepidemiological research--a literature review. Pharmacoepidemiol Drug Saf (2013) 1.53
Protein import channel of the outer mitochondrial membrane: a highly stable Tom40-Tom22 core structure differentially interacts with preproteins, small tom proteins, and import receptors. Mol Cell Biol (2001) 1.53
Ethnic differences in obesity among immigrants from developing countries, in Oslo, Norway. Int J Obes (Lond) (2006) 1.52
The hprK gene of Enterococcus faecalis encodes a novel bifunctional enzyme: the HPr kinase/phosphatase. Mol Microbiol (1999) 1.47
The Alzheimer-like phosphorylation of tau protein reduces microtubule binding and involves Ser-Pro and Thr-Pro motifs. FEBS Lett (1992) 1.45
Consequences of hip fracture on activities of daily life and residential needs. Osteoporos Int (2004) 1.44
Amphiphysin, a novel protein associated with synaptic vesicles. EMBO J (1992) 1.42
Prevalence and predictors of vitamin D deficiency in five immigrant groups living in Oslo, Norway: the Oslo Immigrant Health Study. Eur J Clin Nutr (2005) 1.42
Phosphorylation of microtubule-associated proteins MAP2 and MAP4 by the protein kinase p110mark. Phosphorylation sites and regulation of microtubule dynamics. J Biol Chem (1996) 1.42
Use of ADHD drugs in the Nordic countries: a population-based comparison study. Acta Psychiatr Scand (2010) 1.40
Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol (2002) 1.39
[Is blood pressure treatment as effective in a population setting as in controlled studies?]. Tidsskr Nor Laegeforen (1994) 1.39
GRA7, an excretory 29 kDa Toxoplasma gondii dense granule antigen released by infected host cells. Mol Biochem Parasitol (1998) 1.39
[Use of alendronate in osteoporosis--is it cost-effective?]. Tidsskr Nor Laegeforen (1997) 1.39
[Skiing over Greenland--physical and psychological changes]. Tidsskr Nor Laegeforen (1997) 1.38
Isolation of novel HLA-DR restricted potential tumor-associated antigens from the melanoma cell line FM3. Cancer Res (1997) 1.38
Non-fasting serum triglyceride concentration and mortality from coronary heart disease and any cause in middle aged Norwegian women. BMJ (1993) 1.38
Structural characterization of Dictyostelium discoideum prespore-specific gene D19 and of its product, cell surface glycoprotein PsA. Mol Cell Biol (1988) 1.37
Conformational switch and role of phosphorylation in PAK activation. Mol Cell Biol (2001) 1.37
Identification of 40 S ribosomal protein S6 phosphorylation sites in Swiss mouse 3T3 fibroblasts stimulated with serum. J Biol Chem (1993) 1.36
[Risk of disease in 10,500 travelers to tropical countries and 1,300 tourists to North America]. Schweiz Med Wochenschr (1978) 1.36
Epidemiology of distal forearm fractures in Oslo, Norway. Osteoporos Int (2008) 1.32
Undertreatment and overtreatment with statins: the Oslo Health Study 2000-2001. J Intern Med (2004) 1.31
MAP kinases Erk1/2 phosphorylate sterol regulatory element-binding protein (SREBP)-1a at serine 117 in vitro. J Biol Chem (2000) 1.30
Evidence for a copper-coordinated histidine-tyrosine cross-link in the active site of cytochrome oxidase. Protein Sci (1999) 1.30
Weight gain and the risk of total hip replacement a population-based prospective cohort study of 265,725 individuals. Osteoarthritis Cartilage (2011) 1.26
Phosphorylation-dependent epitopes of neurofilament antibodies on tau protein and relationship with Alzheimer tau. Proc Natl Acad Sci U S A (1992) 1.26
Body mass index and incidence of tuberculosis. Eur J Respir Dis (1986) 1.25
High-density lipoprotein cholesterol and coronary, cardiovascular and all cause mortality among middle-aged Norwegian men and women. Eur Heart J (1992) 1.25
Dietary factors and the incidence of hip fracture in middle-aged Norwegians. A prospective study. Am J Epidemiol (1997) 1.25
Rab11 is associated with GLUT4-containing vesicles and redistributes in response to insulin. Diabetologia (2000) 1.25
Hip geometry, bone mineral distribution, and bone strength in European men and women: the EPOS study. Bone (2000) 1.23
The effect of coffee on blood lipids and blood pressure. Results from a Norwegian cross-sectional study, men and women, 40-42 years. J Clin Epidemiol (1989) 1.22
beta-Glucosylarginine: a new glucose-protein bond in a self-glucosylating protein from sweet corn. FEBS Lett (1995) 1.22
Phosphoamino acid analysis. Proteomics (2001) 1.22
Identification of the site of interaction of the dihydropyridine channel blockers nitrendipine and azidopine with the calcium-channel alpha 1 subunit. EMBO J (1991) 1.20
Prevalent vertebral deformity predicts incident hip though not distal forearm fracture: results from the European Prospective Osteoporosis Study. Osteoporos Int (2001) 1.20
Hip fracture incidence is decreasing in the high incidence area of Oslo, Norway. Osteoporos Int (2012) 1.18
The effects of lifestyle, dietary dairy intake and diabetes on bone density and vertebral deformity prevalence: the EVOS study. Osteoporos Int (2001) 1.17
The Harstad Injury Prevention Study: prevention of burns in small children by a community-based intervention. Burns (1995) 1.17
Determination and location of phosphoserine in proteins and peptides by conversion to S-ethylcysteine. Methods Enzymol (1991) 1.16
The alpha and beta subunits of phosphorylase kinase are homologous: cDNA cloning and primary structure of the beta subunit. Proc Natl Acad Sci U S A (1988) 1.16
Forearm bone mineral density by age in 7,620 men and women: the Tromsø study, a population-based study. Am J Epidemiol (2001) 1.16
Identification of peroxisomal membrane proteins of Saccharomyces cerevisiae by mass spectrometry. Electrophoresis (2001) 1.15
Epidemiology of hip fractures in Norway. Acta Orthop Scand (1985) 1.15
Genetic heterogeneity of steroid sulfatase deficiency revealed with cDNA for human steroid sulfatase. Biochem Biophys Res Commun (1987) 1.14
Incidence of hip fracture in Oslo, Norway: differences within the city. Bone (1998) 1.14
Systolic and diastolic blood pressures as predictors of coronary heart disease in middle aged Norwegian men. Br Med J (Clin Res Ed) (1987) 1.12
The Tromsø Study: physical activity and the incidence of fractures in a middle-aged population. J Bone Miner Res (1998) 1.12
Characterization of the calmodulin-binding sites of muscle phosphofructokinase and comparison with known calmodulin-binding domains. J Biol Chem (1987) 1.11
Epidemiology of fractures of the distal forearm in Oslo, Norway. Acta Orthop Scand (1983) 1.11
Endocytosis via galactose receptors in vivo. Ligand size directs uptake by hepatocytes and/or liver macrophages. Exp Cell Res (1986) 1.10
Local and national electronic databases in Norway demonstrate a varying degree of validity. J Clin Epidemiol (2005) 1.09
Improving risk assessment: hip geometry, bone mineral distribution and bone strength in hip fracture cases and controls. The EPOS study. European Prospective Osteoporosis Study. Osteoporos Int (2002) 1.08
Tea consumption. relationship to cholesterol, blood pressure, and coronary and total mortality. Prev Med (1992) 1.08
Cloning of a cDNA encoding the human cation-dependent mannose 6-phosphate-specific receptor. Proc Natl Acad Sci U S A (1987) 1.07
Paget's disease in Norway. Lancet (1979) 1.07